Health Care & Life Sciences » Pharmaceuticals | Gedeon Richter Nyrt.

Gedeon Richter Nyrt. | Balance Sheet

Fiscal year is January-December. All values HUF Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
110,393
118,920
136,348
96,804
76,085
117,749
Total Accounts Receivable
113,666
104,808
102,289
126,668
136,194
142,479
Inventories
68,687
66,452
64,680
81,246
84,474
92,687
Other Current Assets
6,452
4,534
4,712
5,228
7,778
5,156
Total Current Assets
299,198
294,714
308,029
309,946
304,531
358,071
Net Property, Plant & Equipment
163,453
169,558
177,950
191,002
196,990
214,880
Total Investments and Advances
31,822
13,218
33,554
44,612
48,445
21,342
Long-Term Note Receivable
19,153
20,295
3,683
1,592
1,016
8,661
Intangible Assets
196,597
213,666
215,715
261,309
199,335
187,034
Total Assets
714,144
720,057
746,994
813,877
760,865
797,883
ST Debt & Current Portion LT Debt
5,037
14,525
6,523
7,776
-
Accounts Payable
41,926
36,335
38,209
45,926
47,495
Income Tax Payable
207
281
425
655
703
Other Current Liabilities
25,122
41,329
26,576
34,855
32,988
Total Current Liabilities
72,292
92,470
71,733
89,212
81,186
Long-Term Debt
54,781
44,155
37,188
28,874
3
Provision for Risks & Charges
1,843
2,770
2,928
3,508
3,305
Deferred Taxes
3,767
270
876
546
2,543
Other Liabilities
26,344
10,056
6,668
875
483
Total Liabilities
162,948
158,327
127,456
128,431
92,982
Common Equity (Total)
548,344
558,558
615,252
678,002
659,327
Total Shareholders' Equity
548,344
558,558
615,252
678,002
659,327
Total Equity
551,196
561,730
618,389
681,873
664,019
Liabilities & Shareholders' Equity
714,144
720,057
746,994
813,877
760,865
Accumulated Minority Interest
2,852
3,172
3,137
3,871
4,692
Non-Equity Reserves
-
-
1,149
3,573
3,864

About Gedeon Richter Nyrt.

View Profile
Address
Gyömrõi út 19-21
Budapest BU 1103
Hungary
Employees -
Website http://www.richter.hu
Updated 07/08/2019
The Chemical Works of Gedeon Richter Plc engages in the development and manufacture of pharmaceuticals. It operates through the following segments: Pharmaceuticals, Wholesale and Retail, and Others. The Pharmaceutical segment is comprised of the subsidiaries of the group which are mainly engages in the research and development together with manufacturing and sale of pharmaceutical products.